TransCode shareholders approve 10M share offering and reverse stock split at special meeting

Transcode Therapeutics, Inc.

Ratified issuance of 10M shares of common stock and warrants to ThinkEquity LLC via best-efforts public offering.
Approved reverse stock split at ratio between 1:10 and 1:40, with timing at Board's discretion.
Ratification Proposal: 3,659,491 for, 1,094,753 against, 70,611 abstain (4,655,205 broker non-votes).
Reverse Stock Split Proposal: 7,271,421 for, 2,012,687 against, 195,952 abstain; no broker non-votes.
Adjournment Proposal approved but not needed; total shares present at meeting: 9,480,060 of 17,265,658 entitled.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.